These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31865260)

  • 1. The impact of cannabis access laws on opioid prescribing.
    McMichael BJ; Van Horn RL; Viscusi WK
    J Health Econ; 2020 Jan; 69():102273. PubMed ID: 31865260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort.
    Lopez CD; Boddapati V; Jobin CM; Hickernell TR
    J Am Acad Orthop Surg; 2021 Feb; 29(4):e188-e197. PubMed ID: 32404683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurse Practitioner Scope-of-Practice Laws and Opioid Prescribing.
    McMichael BJ
    Milbank Q; 2021 Sep; 99(3):721-745. PubMed ID: 34187087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of medical and recreational marijuana laws on opioid prescribing in employer-sponsored health insurance.
    Wen J; Wen H; Butler JS; Talbert JC
    Health Econ; 2021 May; 30(5):989-1000. PubMed ID: 33624387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of U.S. State Medical Cannabis Laws on Treatment of Chronic Noncancer Pain.
    McGinty EE; Tormohlen KN; Seewald NJ; Bicket MC; McCourt AD; Rutkow L; White SA; Stuart EA
    Ann Intern Med; 2023 Jul; 176(7):904-912. PubMed ID: 37399549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Supply of Prescription Opioids: Contributions of Episodic-Care Prescribers and High-Quantity Prescribers.
    Schneberk T; Raffetto B; Kim D; Schriger DL
    Ann Emerg Med; 2018 Jun; 71(6):668-673.e3. PubMed ID: 29275945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recreational cannabis and opioid distribution.
    Raman S; Maclean JC; Bradford WD; Drake C
    Health Econ; 2023 Apr; 32(4):747-754. PubMed ID: 36653623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Opioid and Benzodiazepine Poisoning Deaths After Cannabis Legalization in the US: A County-level Analysis, 2002-2020.
    Castillo-Carniglia A; Rivera-Aguirre A; Santaella-Tenorio J; Fink DS; Crystal S; Ponicki W; Gruenewald P; Martins SS; Keyes KM; Cerdá M
    Epidemiology; 2023 Jul; 34(4):467-475. PubMed ID: 36943813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
    Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
    MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
    Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
    J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in Schedule II opioid prescribing by primary care -providers, orthopedic and general surgeons, and pain -management specialists following the implementation of a State House Bill and an Institutional Controlled Substance Task Force.
    Shields LBE; Johnson TA; Daniels MW; Bell A; Siemens DM; Jennings JT; Hester ST; Honaker JT
    J Opioid Manag; 2021; 17(2):155-167. PubMed ID: 33890279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.
    Schieber LZ; Guy GP; Seth P; Young R; Mattson CL; Mikosz CA; Schieber RA
    JAMA Netw Open; 2019 Mar; 2(3):e190665. PubMed ID: 30874783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laws limiting prescribing and dispensing of opioids in the United States, 1989-2019.
    Davis CS; Lieberman AJ
    Addiction; 2021 Jul; 116(7):1817-1827. PubMed ID: 33245795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cannabis laws on opioid use.
    Flexon JL; Stolzenberg L; D'Alessio SJ
    Int J Drug Policy; 2019 Dec; 74():152-159. PubMed ID: 31590091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.
    Meara E; Horwitz JR; Powell W; McClelland L; Zhou W; O'Malley AJ; Morden NE
    N Engl J Med; 2016 Jul; 375(1):44-53. PubMed ID: 27332619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.
    Guy GP; Zhang K; Bohm MK; Losby J; Lewis B; Young R; Murphy LB; Dowell D
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(26):697-704. PubMed ID: 28683056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid prescribing patterns among postpartum women.
    Badreldin N; Grobman WA; Chang KT; Yee LM
    Am J Obstet Gynecol; 2018 Jul; 219(1):103.e1-103.e8. PubMed ID: 29630887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Marijuana Legalization on Opioid Utilization in Patients Diagnosed with Pain.
    Neilson LM; Swift C; Swart ECS; Huang Y; Parekh N; Munshi KD; Henderson R; Good CB
    J Gen Intern Med; 2021 Nov; 36(11):3417-3422. PubMed ID: 33575906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.